Amgen is concentrating revenue through a pharmaceutical wholesaler, which is either Cencora or Cardinal Health.
7 reports, 2 independent
Updated Sep 14
Gone quiet
- Reports
- 7
- Developments
- 1
- Repetition
- 86%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Amgen is concentrating revenue through a pharmaceutical wholesaler, which is either Cencora or Cardinal Health.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Related events
- Amgen Inc. trades on the NASDAQ stock exchange.
- Royalty Pharma acquired a royalty interest in Amgen's drug Imdelltra.
- Amgen and Novartis have developed similar drugs aimed at treating heart conditions.
- Joint drug trial success boosts Amgen stock.
- Both Amdocs and Amgen are currently subject to analyst reviews.